Nexxen International notice to sell 35,000 shares

Nexxen International Ltd. has a notice covering the potential sale of up to 35,000 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $358,050.00.

Accepted by SEC EDGAR 07/16/2026 - 04:10 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Nexxen International Ltd. has a notice covering the potential sale of up to 35,000 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $358,050.00. The filing states that 56,284,083 ordinary shares are outstanding.

The securities to be sold were acquired on 03/31/2026 as 75,386 shares issued upon vesting of RSUs, with no consideration paid. It also lists multiple sales of ordinary shares by Sagi Niri over the past three months, including 71,845 shares for $715,468.53 on 07/13/2026.

Key Figures

Shares to be sold: 35,000 shares Aggregate market value: $358,050.00 Shares outstanding: 56,284,083 shares +3 more

6 metrics

Shares to be sold 35,000 shares Ordinary shares covered by the notice

Aggregate market value $358,050.00 Value of 35,000 ordinary shares covered

Shares outstanding 56,284,083 shares Ordinary shares outstanding listed in the notice

RSU vesting shares 75,386 shares Shares issued upon vesting of RSUs on 03/31/2026

Single-day sale 71,845 shares for $715,468.53 Ordinary shares sold on 07/13/2026 by Sagi Niri

Single-day sale 68,886 shares for $625,582.37 Ordinary shares sold on 06/29/2026 by Sagi Niri

Key Terms

RSUs, No consideration, Ordinary Shares, Nasdaq

4 terms

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

Ordinary Shares financial

"Ordinary Shares | 03/31/2026 | Shares issued"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Nasdaq market

"07/16/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What planned share sale does Nexxen International (NEXN) Form 144 report?

It covers a potential sale of 35,000 ordinary shares with an aggregate market value of $358,050.00. The shares are to be sold through Oppenheimer & Co. Inc. and are listed on Nasdaq. The filing also notes 56,284,083 shares outstanding for the company.

How many Nexxen International (NEXN) shares came from RSU vesting?

On 03/31/2026, 75,386 ordinary shares were issued upon vesting of RSUs with no consideration paid. Nexxen International Ltd. is listed as the issuer, and these vested shares are the source of the securities that may be sold under the notice.

How many Nexxen International (NEXN) shares are outstanding in this notice?

The notice lists 56,284,083 ordinary shares outstanding for Nexxen International. This figure provides context for the planned sale of 35,000 shares, showing the overall equity base relative to the amount that may be sold under this Form 144 filing.

Which broker is named for the Nexxen International (NEXN) share sale?

Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, is named as the broker. This firm would handle the sale of up to 35,000 Nexxen ordinary shares listed on Nasdaq, according to the Form 144 disclosure.

What recent Nexxen International (NEXN) share sales by Sagi Niri are disclosed?

Multiple past sales by Sagi Niri are disclosed, including 71,845 shares sold for $715,468.53 on 07/13/2026. Additional transactions span from 05/29/2026 to 07/15/2026, with varying share amounts and aggregate prices over the preceding three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001980194
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nexxen International Ltd.
SEC File Number	001-40504
Address of Issuer	82 YIGAL ALON STREET 13TH FLOOR TEL AVIV ISRAEL 6789124
Phone	972-3-545-3900
Name of Person for Whose Account the Securities are To Be Sold	Niri Sagi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	35000	358050.00	56284083	07/16/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	03/31/2026	Shares issued upon vesting of RSUs	Nexxen International Ltd.			75386	03/31/2026	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sagi Niri 82 YIGAL ALON STREET Tel Aviv L3 6789124	Ordinary Shares	05/29/2026	1486	12635.90
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/01/2026	33757	291289.73
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/02/2026	18660	159055.97
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/03/2026	1100	9438.00
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/04/2026	13164	112376.00
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/10/2026	5922	51755.32
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/12/2026	200	1740.00
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/15/2026	1160	10100.12
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/16/2026	34667	304459.77
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/17/2026	2098	18412.68
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/29/2026	68886	625582.37
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	06/30/2026	6183	56441.52
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/01/2026	42692	399739.24
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/02/2026	49826	475574.20
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/06/2026	199	1898.46
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/10/2026	3655	35580.33
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/13/2026	71845	715468.53
Sagi Niri 82 Yigal Alon Street Tel Aviv L3 6789124	Ordinary Shares	07/15/2026	34500	350468.25

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 08/19/2025
Date of Notice	07/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Sagi Niri By: /s/ Liron Avigdor Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)